INTRODUCTION
Hepatic encephalopathy (HE) is a syndrome of neuropsychiatric dysfunction disease [1] . Hepatic encephalopathy is a common complication of advanced cirrhosis. Between one third to one half of hospitalizations for cirrhosis are related to HE. The frequency of hospitalization for HE has nearly doubled over the last decade, with lengths of stay between 5 and 7 days [2] . Patients with HE often have other manifestations of end-stage liver disease, such as ascites, jaundice, or gastrointestinal variceal bleeding. Hepatic encephalopathy can also develop as an isolated manifestation of decompensated cirrhosis. Hepatic encephalopathy usually signals advanced liver failure, and is often considered a clinical indication for evaluation for liver transplantation . HE may disable the patient from employment , driving and self-care, and require involvement of family or household members in the care of affected patients [3] .
HE is clinically classified into three major categories, according to the underlying hepatic condition. Type A occurs in patients with acute liver failure. Type B occurs in patients without intrinsic liver disease but with large, noncirrhotic, portosystemic shunting. Type C is related to underlying cirrhosis with portosystemic shunting. Type C is the most common form, It can be divided to episodic or persistent [4] .
MRI may help in diagnosis of hepatic encephalopathy, the most frequent conventional MR finding in hepatic encephalopathy is T1 weight image that gives high signal intensity of the basal ganglia caused mainly by deposition of manganese [5] and T2 caused by diffuse brain edema which seems to play an essential role in the pathogenesis of hepatic encephalopathy, which is believed to be related to the portosystemic shunt and increase level of ammonia, Changes found in conventaial MRI T1and T2 have no quantitative relation to severity of HE [1, 2] . MR spectroscopy (MRS) provides a measure of brain chemistry and metabolic changes which occurs in the astrocytes in patients with chronic liver cell failure which showing increase in glutaminel glutamate signal intensity and decrease myo-inosital and choline signal intensity to prevent massive cerebral edema. Changes seen on MRS imaging usually correlate with severity of hepatic encephalolpathy [6] .
PATIENTS AND METHODS
This study was conducted in the Tropical Medicine and Radiology Departments, Zagazig University Hospitals from January 2009 to January 2012. The study included 60 patients with liver cirrhosis; 40 of them were chronic hepatic encephalopathy, (20 patients persistent hepatic encephalopathy with grade I-II after taking treatment and 20 patients relapsing hepatic encephalopathy, showed normal psychometric test), 20 of them early compensated cirrhosis as a control. The patients diagnosed for hepatic encephalopathy using psychometric tests and Grading of the symptoms of hepatic encephalopathy is performed according to the West Haven classification system.
All patients were divided into three groups:
Group I: (Chronic persistent hepatic encephalopathy)
It included twenty patients, 15 out of them were males, 5 patients were females, their ages ranged between 43-73 years.
Inclusion criteria for this group (GI)
Patients had changes in consciousness, intellectual function and behavior. Gait abnormalities and flapping tremors (grade I, II by west haven criteria) were included in this group.
Group II (Chronic relapsing hepatic encephalopathy)
It included twenty patients (14 patients were males, 6 patients were females) their ages ranged between 46-67 years.
Inclusion criteria for this group (GII)
Patients who had frequent episodes of acute HE and after examination. The patients were perfectly alert don't showed any sign of cognitive dysfunction and psuychometric test for all patients negative.
Group III: (early compensated cirrhosis)
It included twenty patients with no previous episodes of HE in these group, 16 were males and 4 were female their ages ranged between 42-67 years (G III).
Exclusion Criteria:
Patients with neuropathological evidence of trauma, tumor, Cerebrovascular accident or neurodegenerative disease (Alzheimer's disease or Parkinson diseases) will be excluded from the study regardless the presence of liver disorder. 
4-Complete neuropsychological assessment by
using psychometric tests (number connection test (NCT), circle connection test (CCT) [7] .
5) Magnetic resonance imaging
Routine MRI was done for all patients. MR imaging consisted of transverse nonenhanced T1-weighted spin-echo and T2-weighted fast spin-echo sequences. The imaging parameters were 500/14 msec (repetition time msec/echo time msec), FOV: 230x 230 mm and a 2-minute acquisition time for T1-weighted imaging and 5000/86 msec (TR/TE msec), FOV: 230x 230 mm and a 3-minute acquisition time for T2-fast spin echo sequences. The section thickness was 5 mm with an intersection gap of 1 mm.
-1 H MR spectroscopy:
A-Localization and data acquisition: was achieved by acquiring three orthogonal.
(sagittal, transverse, and coronal) gapless, HASTE sequences. Before recording the spectrum, the homogeneity of the magnetic field over the volume of interest was optimized by shimming. Suppression of water signal was performed by using three preceding Gaussian pulses (60-Hz bandwidth). Then multi-voxel PRESS technique using the following parameters TR: 1500 msec, TE: 30 msec and FOV: 230x 230mm was done.
B-Post processing: Spectral postprocessing consisted of zero filling Gaussian apodiztion for noise reduction with base line and phase correction.
C-Spectral analysis: Measurement was performed at following resonance myoinositol (mI) (3.5 ppm), glutamate or glutamine (Glx ) (3.75 ppm), creatine (Cr} (3.03 ppm),Cho (3.22 ppm), and N-acetylaspartate (NAA} (2.0 ppm). Those metabolites were measured in the in deep white matter in the medial part of the occipital lobe, parietal. lobe and basal ganglionic regions. Metabolic ratios were calculated for mI/Cr, Cho/Cr, Glx/Cr and Na/Cr ratios in all our subjects.
Statistical analysis
Statistical were calculated using SPSS windows (version 10). Qualitative variables were expressed by means of frequency and percentiles, and were analyzed using the X 2 test. Quantitative results are expressed as meansSD. Groups were compared by using paired t-test, ANOVA or thine Wilcoxon signed-rank test.
RESULTS
There were no significant difference in epidemiological and biochemical parameters among patients of the three groups of the study apart from statistical significant increase in serum bilrubin and reduction in serum albumin and prothrombine concentration in GI compared to other groups. Child score was high among patient in GI (11.51.54) in comparison to group II (9.52.6) and III (5.50.5) with P<0.001 (Table 1) .
There was significant increased in signal intensity of T1 and T2 in group I compared with other groups with complete absence of signal among GIII with (P<0.001) ( Figure 1&2 ).
A significant high serum level of ammonia in GI (162.155.8 mol/L) and high serum level of manganes in GI (3.350.34 ug/dl) was noticed when compared to other groups with P<0.001 (Table 4) .
Relation between Mn level in blood & T1 signal image in hepatic patients, there was significant elevation in signal intensity in T1 in corresponding to elevation of level of Mn in blood (2.910.6 ug/dl) with P<0.001 (Table 5 ).
A relation between ammonia level in blood and T 2 signal intensity in hepatic patients, there was significant elevation in signal intensity in T2 in corresponding to elevation of level of ammonia in blood (116.949 mol/L) P<0.001 (Table 6) .
A correlation between ammonia and chemical metabolities we found, MR spectroscopy revealed highly significant positive correlation between ammonia in blood and glutamine in the brain (r = 0.86, P<0.001) as well as highly significant negative correlation between ammonia in blood and Choline (r = -0.42, P<0.01) or Myinstol (r =-0.47, P<0.001) in the brain (Table 7) . 
DISCUSSION
Hepatic encephalopathy includes a spectrum of neuropsychiatric abnormalities occurring in patients with liver dysfunction. Most cases are associated with cirrhosis and portal hypertension or portal-systemic shunts, but the condition can also be seen in patients with acute liver failure and not associated with intrinsic hepatocellualr disease [8] . Chronic HE can be subclassified into relapsing HE and persistent HE. Relapsing HE manifests as frequent episodes of acute HE that may be due to precipitating factors, these patients can be perfectly alert and don't show any sign of cognitive dysfunction. However, a careful neurologic examination and neuropsychological tests may reveal subtle abnormalities. Persistent HE refers to manifestations that do not reverse despite adequate treatment [3] .
The liver and brain interact in numerous ways to ensure normal brain function. By using MR imaging for diagnosis there was increase in substances that under normal circumstances are efficiently metabolized by the liver. Classic MR imaging abnormalities include on T 1 -weighted images due to high signal intensity in the globus pallidum caused by increased tissue concentrations of manganese, as well as elevated glutamine/glutamate peak coupled with decreased myoinositol and choline signals on proton MR spectroscopy representing disturbances in cell-volume homeostasis secondary to brain hyperammonemia to protect astrocyte [9] .
In the present study we found high statistically significant increase in serum level of ammonia and manganese in chronic persistent hepatic encephalopathy when compared to other groups. So serum ammonia and manganese increase with the degree of brain affection these results agreed with that reported by Butterworth et al. [10] and Rose et al. [11] .
Our results showed significant increase signal intensity of T 1 and T 2 in chronic persistent HE compared to chronic relapsing HE that agreed with Weissenborn et al. [12] , also significant elevation of signal intensity of T2 and T1 corresponding to elevation of serum level of ammonia and manganese respectively were detected .This agreed with Rovira et al. [3] who found that liver transplantationt provides normalization of both the MRI abnormalities and Mn levels seem to confirm the suspicion of manganese being the responsible agent for the hyperintensity of T1-weighted images .
Signal alterations in T2-weighted MR images in chronic HE are less frequently reported. However, there have been studies showing T2 hyperintensity along the cortico-spinal tract in the brain of cirrhotic patients which were reversed after liver transplantation using the fastfluid attenuation inversion recovery (FLAIR) sequence [13] .
Moreover we found MRS that showed different metabolic changes of the brain in these patients, significant increase in glutamine and significant reduction in choline and myomositol in patients with chronic persistent HE compared to other groups .Our result agreed with those of Ross et al. [14] ; Kreis et al. [15] and Rovira et al. [3] and disagree with this study Kostter [16] and Lee et al. [17] in which no difference in 1H-MR spectroscopy finding between patients with and without HE.
Correlation between ammonia and chemical metabolites found in MR spectroscopy revealed highly significant positive correlation between ammonia in blood and glutamine in the brain as well as highly significant negative correlation between ammonia in blood and Choline or Myinstol in the brain were seen .
In chronic hepatic encephalopathy decreased urea cycle activity result in increased level of ammonia with increase synthesis of cerebral glutamine in astrocyte. The effects of increased intracellular glutamate include a reduction in K uptake an increased in Cl uptake which leads to reduction in Myinstol and Choline to prevent more brain edema and astrocyte damage [18] . The current study showed that level of ammonia and manganese correlate with MRI images and with MRS metabolites moreover this study showed significant difference in different grades of hepatic encephalopathy.
Diagnosis of patients of chronic persistent hepatic encephalopathy can be easily done by measuring the chemical parameters so by collectively, MRI, MRS, and estimation of serum manganese and ammonia can told us to prioritize patients of chronic hepatic encephalopathy for liver transplantation.
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